All-at-Once Spatial Proteome Profiling with Single-Cell-Type Resolution: Insights from PSPro

Study Background and Research Question

Multicellular tissues are composed of diverse cell types, each contributing uniquely to physiological or pathological states. Understanding the molecular heterogeneity and spatial architecture of these cell populations is critical for deciphering mechanisms underlying tissue homeostasis and disease progression. Conventional spatial proteomics approaches, such as laser microdissection-mass spectrometry (LMD-MS) and antibody-based imaging, have advanced tissue profiling, yet they are limited by trade-offs between spatial resolution, proteome coverage, and throughput. Mao et al. aimed to address these limitations by developing a methodology capable of comprehensive, spatially resolved proteome mapping with single-cell-type specificity in complex tissue contexts (Mao et al., 2025).

Key Innovation from the Reference Study

The central innovation presented by Mao et al. is the PSPro (Proximity labeling for Spatial Proteomics) workflow. PSPro leverages antibody-targeted proximity biotinylation coupled with efficient affinity purification to capture the proteomes of specific cell types in situ. Uniquely, this strategy allows for the parallel enrichment and identification of thousands of proteins from multiple cell types within a single tissue slice, achieving sub-micrometer spatial precision. Unlike conventional LMD-MS, which is constrained by the physical dissection of regions and associated throughput bottlenecks, PSPro's all-at-once biotinylation bypasses the need for sequential microdissection, thus preserving both spatial and cell-type fidelity (Mao et al., 2025).

Methods and Experimental Design Insights

PSPro integrates several key methodological elements:

• Antibody-Targeted Proximity Labeling: Tissue sections are incubated with primary antibodies against cell-type-specific surface markers. Horseradish peroxidase (HRP)-conjugated secondary antibodies are then applied, catalyzing the localized deposition of biotinylated tyramide onto adjacent proteins within nanometer-scale proximity.
• Optimization of Labeling Parameters: The study systematically tuned labeling conditions—including tyramide concentration, reaction time, and HRP activity—to maximize selectivity and proteome coverage while minimizing off-target labeling.
• Affinity Purification and Mass Spectrometry: Biotinylated proteins are selectively enriched via streptavidin-based affinity capture, followed by mass spectrometry-based proteome identification and quantitation.
• Integration with Laser Microdissection: For finer spatial resolution, PSPro can be combined with LMD to isolate discrete tissue regions post-labeling, enabling direct comparison of proteomic profiles between spatially distinct subpopulations within the same slice.

This workflow was benchmarked against established flow cytometry- and LMD-based proteomic pipelines, demonstrating comparable or superior performance in both selectivity and depth (Mao et al., 2025).

Protocol Parameters

• assay: tyramide signal amplification | value_with_unit: variable (optimized per marker, e.g., 1–10 μM tyramide) | applicability: cell surface protein labeling in tissue | rationale: balances labeling selectivity and proteome depth | source_type: paper
• assay: antibody incubation | value_with_unit: 1–2 hours at RT | applicability: primary and HRP-conjugated secondary | rationale: ensures sufficient target binding | source_type: paper
• assay: HRP-catalyzed biotinylation | value_with_unit: 10–30 min reaction | applicability: proximity labeling in situ | rationale: minimizes background, maximizes signal | source_type: paper
• assay: affinity purification | value_with_unit: standard streptavidin pulldown | applicability: biotinylated proteome enrichment | rationale: robust separation of labeled vs. unlabeled proteins | source_type: paper
• assay: mass spectrometry | value_with_unit: LC-MS/MS standard settings | applicability: identification/quantification of enriched proteins | rationale: established sensitivity and reproducibility | source_type: paper
• assay: tyramide variant selection | value_with_unit: use membrane-impermeant, long-linker tyramides (e.g., biotin-LC-LC-tyramide) | applicability: restricts labeling to cell surface | rationale: avoids intracellular background | source_type: workflow_recommendation

Core Findings and Why They Matter

Mao et al. applied PSPro to both pancreatic tumor and spleen tissue slices, successfully capturing the proteomes of ten distinct cell types within a single experiment. The workflow enabled the enrichment of thousands of proteins per cell type, including established marker proteins, and revealed pronounced spatial heterogeneity among cancer and immune cell subsets. By incorporating LMD with PSPro, the authors demonstrated direct spatial comparison of subpopulations within the same tissue context—a capability not readily achievable with conventional methods (Mao et al., 2025).

This all-at-once approach advances spatial proteomics by minimizing sample loss, reducing batch effects, and increasing throughput. It also offers a scalable path to map complex tissue architectures and cell-cell interactions, informing both basic biology and translational research into tumor microenvironments, immune niches, and tissue organization.

Comparison with Existing Internal Articles

Recent internal resources highlight the strengths of membrane-impermeant tyramide derivatives, such as Biotin-XX Tyramide Reagent, for high-fidelity cell surface protein labeling and signal amplification in immunohistochemistry (IHC) and in situ hybridization (ISH) workflows (internal article 1, internal article 2). These articles emphasize robust selectivity, sensitivity, and the importance of minimizing intracellular signal by using long-linker, membrane-impermeant probes. The PSPro workflow aligns with these principles, employing biotin-LC-LC-tyramide analogues to restrict labeling to cell surfaces, thus ensuring spatial precision and minimizing background. While the internal articles provide best practices and product-specific validation, the reference study extends these findings by demonstrating system-wide, cell-type-resolved proteomics in situ using such reagents.

Limitations and Transferability

Despite its significant advances, PSPro has limitations. The approach is contingent on the availability and specificity of high-quality antibodies for cell surface markers, and labeling is mostly restricted to accessible, membrane-proximal proteins. Intracellular proteomes or those not exposed on the cell surface remain less accessible with this technique. Additionally, as with all mass spectrometry-based workflows, protein detection is influenced by abundance, extraction efficiency, and MS sensitivity. Transferability to other tissue types or rare cell populations will require optimization of antibody panels and labeling conditions (Mao et al., 2025).

Research Support Resources

To implement proximity labeling workflows similar to PSPro, researchers can utilize membrane-impermeant, long-linker tyramide reagents such as Biotin-XX Tyramide Reagent (SKU A8012) from APExBIO. This reagent is optimized for HRP-catalyzed, cell surface-restricted biotinylation and is compatible with tyramide signal amplification protocols in IHC, ISH, and spatial proteomics. For detailed evidence on labeling selectivity and workflow integration, see both Mao et al. (reference) and relevant internal guidance.